Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

Background Vascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical. Methods and Findings Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Müller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Müller cell line in vitro supports the existence of an autocrine role for VEGF in Müller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective. Conclusions These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution.

[1]  J. Takahashi,et al.  Interpretation of the mouse electroretinogram , 2007, Documenta Ophthalmologica.

[2]  Susan Schneider,et al.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[3]  A. Cellerino,et al.  Molecular determinants of retinal ganglion cell development, survival, and regeneration , 2003, Progress in Retinal and Eye Research.

[4]  J. Williamson,et al.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. , 1997, The Journal of clinical investigation.

[5]  E. Vecino,et al.  Role of Müller glia in neuroprotection and regeneration in the retina. , 2003, Histology and histopathology.

[6]  Ingeborg Stalmans,et al.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. , 2002, The Journal of clinical investigation.

[7]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  M. Sunday,et al.  Differential expression of VEGF isoforms in mouse during development and in the adult , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  H. Ishii,et al.  Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[10]  R. Linsenmeier Electrophysiological consequences of retinal hypoxia , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  Magali Saint-Geniez,et al.  Development and pathology of the hyaloid, choroidal and retinal vasculature. , 2004, The International journal of developmental biology.

[12]  C. Gerhardinger,et al.  Expression of acute-phase response proteins in retinal Müller cells in diabetes. , 2005, Investigative ophthalmology & visual science.

[13]  M. Silverman,et al.  Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse. , 1997, Ophthalmic research.

[14]  N. Kinkl,et al.  Survival of Purified Rat Photoreceptors In Vitro Is Stimulated Directly by Fibroblast Growth Factor-2 , 1998, The Journal of Neuroscience.

[15]  J. Jonas,et al.  Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. , 2006, American journal of ophthalmology.

[16]  G. Lewis,et al.  Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. , 2003, International review of cytology.

[17]  J. Rossant,et al.  Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. , 1999, Developmental biology.

[18]  M. Cooper,et al.  Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[19]  E. Newman,et al.  The Müller cell: a functional element of the retina , 1996, Trends in Neurosciences.

[20]  J. Whittum-Hudson,et al.  Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy: association with inflammation and viral infection. , 2001, Histology and histopathology.

[21]  M. Neeman,et al.  Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes , 1995, Molecular and cellular biology.

[22]  R. D'Amato,et al.  Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Shih,et al.  Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  L. Maffei,et al.  Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina , 1991, Experimental Neurology.

[25]  R. Engerman,et al.  Cell turnover of capillaries. , 1967, Laboratory investigation; a journal of technical methods and pathology.

[26]  H. Nawa,et al.  BDNF is upregulated by postnatal development and visual experience: quantitative and immunohistochemical analyses of BDNF in the rat retina. , 2003, Investigative ophthalmology & visual science.

[27]  Claudio Campa,et al.  Targeting VEGF-A to treat cancer and age-related macular degeneration. , 2007, Annual review of medicine.

[28]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[29]  D. Cogan,et al.  The mural cell in perspective. , 1967, Archives of ophthalmology.

[30]  N. Himes,et al.  VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma , 2008, The Journal of experimental medicine.

[31]  Y. Tano,et al.  Retinal pigment epithelial lesions associated with choroidal ischemia in preeclampsia. , 1998, Retina.

[32]  R. Bachelder,et al.  Autocrine signaling in carcinoma: VEGF and the α6β4 integrin , 2004 .

[33]  R. Masland,et al.  The Major Cell Populations of the Mouse Retina , 1998, The Journal of Neuroscience.

[34]  M. Kanje,et al.  Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk‐1 receptor , 2000, The European journal of neuroscience.

[35]  N. Osborne,et al.  Expression of Neurotrophins and their Receptors Within the Glial Cells of Retina and Optic Nerve , 1998 .

[36]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[37]  P. D’Amore Vascular endothelial cell growth factor-a: not just for endothelial cells anymore. , 2007, The American journal of pathology.

[38]  C. Zucker,et al.  Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. , 1998, The American journal of pathology.

[39]  Akiyoshi Uemura,et al.  Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. , 2002, The Journal of clinical investigation.

[40]  F. Guan,et al.  Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. , 2006, American journal of physiology. Renal physiology.

[41]  I. Zachary Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. , 2001, American journal of physiology. Cell physiology.

[42]  J. Minna,et al.  Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. , 2000, Cancer research.

[43]  C. Culmsee,et al.  p53 in neuronal apoptosis. , 2005, Biochemical and biophysical research communications.

[44]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[45]  D. Hicks,et al.  Effects of müller glia on cell survival and neuritogenesis in adult porcine retina in vitro. , 2002, Investigative ophthalmology & visual science.

[46]  D TOUSSAINT,et al.  Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.

[47]  G. A. Limb,et al.  In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1). , 2002, Investigative ophthalmology & visual science.

[48]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[49]  D. Darland,et al.  TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells , 2004, Angiogenesis.

[50]  P. D’Amore,et al.  Contextual role for angiopoietins and TGFβ1 in blood vessel stabilization , 2007, Journal of Cell Science.

[51]  R. Bachelder,et al.  Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin. , 2004, Seminars in cancer biology.

[52]  Magali Saint-Geniez,et al.  VEGF expression and receptor activation in the choroid during development and in the adult. , 2006, Investigative ophthalmology & visual science.

[53]  Y. Enokido,et al.  [Neuronal apoptosis]. , 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[54]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[55]  P. Heiduschka,et al.  Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. , 2007, American journal of ophthalmology.

[56]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[57]  Ivana K. Kim,et al.  Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.

[58]  P E Thorpe,et al.  Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[59]  S. Dias,et al.  Autocrine VEGF loops, signaling pathways, and acute leukemia regulation , 2007, Leukemia & lymphoma.

[60]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.

[61]  W. Stallcup,et al.  NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[62]  P. Walter,et al.  Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. , 2007, American journal of ophthalmology.

[63]  David T. Shima,et al.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. , 2007, The American journal of pathology.

[64]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[65]  T. Acker,et al.  Direct Stimulation of Adult Neural Stem Cells In Vitro and Neurogenesis In Vivo by Vascular Endothelial Growth Factor , 2004, Brain pathology.

[66]  M. Saint-Geniez,et al.  Vascular endothelial growth factor localization in the adult. , 2006, The American journal of pathology.

[67]  E. Piek,et al.  Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. , 2003, Developmental biology.

[68]  Kenneth P. Roos,et al.  Autocrine VEGF Signaling Is Required for Vascular Homeostasis , 2007, Cell.

[69]  E. V. Famiglietti,et al.  Immunocytochemical localization of vascular endothelial growth factor in neurons and glial cells of human retina , 2003, Brain Research.

[70]  Betty Y. Y. Tam,et al.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. , 2006, American journal of physiology. Heart and circulatory physiology.

[71]  Alan W. Stitt,et al.  Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra‐ocular tumours , 1998, The Journal of pathology.

[72]  P. Campochiaro,et al.  Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. , 2004, American journal of ophthalmology.

[73]  L. Eng,et al.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. , 1972, Brain research.

[74]  D. Antonetti,et al.  Vascular permeability in ocular disease and the role of tight junctions , 2007, Angiogenesis.

[75]  J. Arnold,et al.  Bilateral choroidal ischaemia and serous retinal detachment in pre‐eclampsia , 2000, Clinical & experimental ophthalmology.

[76]  P. Carmeliet,et al.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model , 2004, Nature.

[77]  R. Kendall,et al.  Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. , 1996, Biochemical and biophysical research communications.

[78]  K. Jin,et al.  Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice , 2007, The Journal of Neuroscience.

[79]  B. Olsen,et al.  Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. , 2005, The American journal of pathology.

[80]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[81]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[82]  B. Bryan,et al.  Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. , 2007, Molecular biology of the cell.

[83]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.